Details
| Stereochemistry | ABSOLUTE |
| Molecular Formula | C28H34FN7O2.2C7H8O3S |
| Molecular Weight | 864.017 |
| Optical Activity | UNSPECIFIED |
| Defined Stereocenters | 3 / 3 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
CC1=CC=C(C=C1)S(O)(=O)=O.CC2=CC=C(C=C2)S(O)(=O)=O.CN3CCN(CC3)C(=O)[C@H](CCCN[C@@H]4C[C@H]4C5=CC=C(F)C=C5)NC(=O)C6=CC=C(C=C6)N7C=CN=N7
InChI
InChIKey=WLRWBXFBIJMKHG-DVNXTAPYSA-N
InChI=1S/C28H34FN7O2.2C7H8O3S/c1-34-15-17-35(18-16-34)28(38)25(3-2-12-30-26-19-24(26)20-4-8-22(29)9-5-20)32-27(37)21-6-10-23(11-7-21)36-14-13-31-33-36;2*1-6-2-4-7(5-3-6)11(8,9)10/h4-11,13-14,24-26,30H,2-3,12,15-19H2,1H3,(H,32,37);2*2-5H,1H3,(H,8,9,10)/t24-,25-,26+;;/m0../s1
| Molecular Formula | C28H34FN7O2 |
| Molecular Weight | 519.6137 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ABSOLUTE |
| Additional Stereochemistry | No |
| Defined Stereocenters | 3 / 3 |
| E/Z Centers | 0 |
| Optical Activity | UNSPECIFIED |
| Molecular Formula | C7H8O3S |
| Molecular Weight | 172.202 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
Approval Year
| Substance Class |
Chemical
Created
by
admin
on
Edited
Tue Apr 01 17:43:52 GMT 2025
by
admin
on
Tue Apr 01 17:43:52 GMT 2025
|
| Record UNII |
2PYF2U9JNF
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Preferred Name | English | ||
|
Official Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Systematic Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
FDA ORPHAN DRUG |
553716
Created by
admin on Tue Apr 01 17:43:52 GMT 2025 , Edited by admin on Tue Apr 01 17:43:52 GMT 2025
|
||
|
FDA ORPHAN DRUG |
565516
Created by
admin on Tue Apr 01 17:43:52 GMT 2025 , Edited by admin on Tue Apr 01 17:43:52 GMT 2025
|
||
|
EU-Orphan Drug |
EU/3/16/1757
Created by
admin on Tue Apr 01 17:43:52 GMT 2025 , Edited by admin on Tue Apr 01 17:43:52 GMT 2025
|
||
|
FDA ORPHAN DRUG |
660418
Created by
admin on Tue Apr 01 17:43:52 GMT 2025 , Edited by admin on Tue Apr 01 17:43:52 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
1990504-72-7
Created by
admin on Tue Apr 01 17:43:52 GMT 2025 , Edited by admin on Tue Apr 01 17:43:52 GMT 2025
|
PRIMARY | |||
|
SUB194611
Created by
admin on Tue Apr 01 17:43:52 GMT 2025 , Edited by admin on Tue Apr 01 17:43:52 GMT 2025
|
PRIMARY | |||
|
C186383
Created by
admin on Tue Apr 01 17:43:52 GMT 2025 , Edited by admin on Tue Apr 01 17:43:52 GMT 2025
|
PRIMARY | |||
|
2PYF2U9JNF
Created by
admin on Tue Apr 01 17:43:52 GMT 2025 , Edited by admin on Tue Apr 01 17:43:52 GMT 2025
|
PRIMARY | |||
|
131801105
Created by
admin on Tue Apr 01 17:43:52 GMT 2025 , Edited by admin on Tue Apr 01 17:43:52 GMT 2025
|
PRIMARY | |||
|
100000180529
Created by
admin on Tue Apr 01 17:43:52 GMT 2025 , Edited by admin on Tue Apr 01 17:43:52 GMT 2025
|
PRIMARY | |||
|
JK-223
Created by
admin on Tue Apr 01 17:43:52 GMT 2025 , Edited by admin on Tue Apr 01 17:43:52 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
PARENT -> SALT/SOLVATE |
|
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |
|